Death from pacemaker implantation surgery is rare, but it is not zero-risk. In large registries, roughly one to two percent of patients die within 30 days of the procedure, though most of those deaths trace back to the underlying heart disease or other serious health problems rather than to the surgery itself. One study of over 2,300 implantations found that no death was directly caused by the pacemaker procedure, even though the overall 30-day mortality rate was about 1.6%.1Revista Española de CardiologÃa. Retrospective Study of Patients Who Go Pacemaker Implantation in Short-Stay Ambulatory Surgery. Long-Term Follow-up and Cost Analysis The real picture depends on what complications arise, the patient’s overall health, and whether the procedure is a first implantation or a later lead extraction or revision.
How Often Do People Die Shortly After Implantation?
For a straightforward first-time pacemaker implantation, the in-hospital death rate is under two percent in most modern series. A large Australian study comparing public and private patients found in-hospital mortality of about 0.7% for healthier patients and 1.3% for sicker ones, with 30-day mortality between 1.3% and 2.1%.2PubMed. Using quality indicators to compare outcomes of permanent cardiac pacemaker implantation among publicly and privately funded patients A study looking at patients who received a pacemaker after aortic valve replacement surgery reported 30-day mortality of 2.4%, though those patients were recovering from open-heart surgery as well, not just the pacemaker itself.3Annals of Thoracic Surgery. Long-Term Mortality Effect of Early Pacemaker Implantation After Surgical Aortic Valve Replacement
The important nuance here is that “dying after pacemaker surgery” is not the same as “dying because of pacemaker surgery.” Most people getting a pacemaker are elderly, have significant heart disease, and often have other conditions like kidney problems or diabetes. When a patient dies within 30 days, the cause is far more often a progression of those underlying problems than a complication from the implant procedure. Still, certain procedural complications can be directly fatal, and those deserve a clear-eyed look.
Complications That Can Turn Life-Threatening
The procedure typically involves threading one or two thin wires (leads) through a vein into the heart, then connecting them to a pulse generator tucked under the skin near the collarbone. Several things can go wrong during or shortly after this process.
Cardiac perforation happens when a lead punctures through the heart wall. This is rare but dangerous because it can cause cardiac tamponade, a condition where blood fills the sac around the heart and compresses it, blocking its ability to pump. Without rapid intervention, tamponade is fatal. Case series describe this as a rare but potentially life-threatening complication of pacemaker leads.4SAGE Open Medicine. Pacemaker leads and cardiac perforation
Pneumothorax, a collapsed lung, occurs when the needle used to access the subclavian vein accidentally punctures the lung. This happens in roughly one percent of procedures.5ACS Case Reviews. Delayed Pneumothorax and Lead Dislodgement after Pacemaker Insertion in a Patient Using Nightly CPAP Most cases are partial and resolve on their own or with a small chest tube. A study of 421 subclavian punctures found that about 0.7% resulted in a nearly complete pneumothorax requiring a chest tube and extended hospital stays of three to six days.6PubMed Central. Pneumothorax resulting from subclavian puncture: a complication of permanent pacemaker lead implantation Pneumothorax is rarely fatal on its own if recognized and treated promptly, but a missed or delayed diagnosis can be dangerous.
Major vascular injury is even rarer. One published case involved a 79-year-old man who developed hemorrhagic shock from a pseudoaneurysm of the subclavian artery after pacemaker insertion, requiring emergency surgery.7Journal of Arrhythmia. A case of unstable occult arterial bleeding post pacemaker implantation These are extreme outliers, but they illustrate why patients are monitored closely in the hours after the procedure.
Lead Dislodgement and Loss of Pacing
After the procedure, one of the more common early complications is lead dislodgement, where a wire shifts from its anchored position in the heart. This typically happens within the first one to two days but can occur up to several months later.8PubMed Central. Navigating Complications in Cardiac Pacemakers: A Comprehensive Review and Management Strategies For most patients, a dislodged lead is an inconvenience requiring a second procedure to reposition it. But for patients who are entirely dependent on their pacemaker for every heartbeat, loss of pacing can cause fainting or cardiac arrest. A case report documented sudden cardiac death 13 days after device implantation due to lead dislodgement in a patient with a severely weakened heart.9PubMed. Automatic implantable cardioverter defibrillator lead dislodgement resulting in sudden cardiac death: a case report
This risk is highest in people whose hearts cannot generate a reliable rhythm on their own. If you still have some underlying heart rhythm and the pacemaker is mainly there as a backup, a dislodged lead is much less dangerous.
When Infection Becomes the Real Danger
Infection is not an immediate surgical risk in the traditional sense, but it is one of the most serious complications that can follow pacemaker surgery. The pocket where the generator sits under the skin, and the leads running through the bloodstream, can become colonized by bacteria. Infection rates for conventional transvenous pacemakers range from about 0.8% to 2%.10Heart Rhythm. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms That may sound small, but the consequences of a pacemaker infection are severe.
If bacteria reach the leads inside the heart, the result is device-related endocarditis, an infection of the heart’s inner lining. In-hospital mortality for this condition runs about 28% in one prospective study tracking 82 patients over more than a decade.11PubMed Central. Predictors of Mortality in Patients with Cardiac Device-Related Infective Endocarditis Broader estimates place in-hospital mortality from pacemaker-associated infections at 5% to 15%, and untreated infections carry an even higher death rate.12PubMed Central. The Diagnosis and Treatment of Pacemaker-Associated Infection Treatment usually requires removing the entire device, including all leads, and weeks of intravenous antibiotics before a new system can be implanted. That extraction itself adds another layer of risk, as discussed below.
Blood Thinners and Pocket Bleeding
Many pacemaker patients take blood-thinning medications for atrial fibrillation, mechanical heart valves, or blood clots. Managing these drugs around surgery creates a balancing act: stop the blood thinner and risk a stroke, or continue it and risk excessive bleeding at the surgical site.
A landmark trial in the New England Journal of Medicine found that patients who continued warfarin through the procedure had a pocket hematoma rate of only 3.5%, compared with 16% in those who switched to a bridging blood thinner called heparin.13PubMed. Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation Pocket hematomas are usually not life-threatening on their own, but they increase infection risk, extend hospital stays, and occasionally require reoperation. The antiplatelet drug clopidogrel is another concern: patients who continued it right up to implantation had hematoma rates above 18%, while those who stopped it more than four days before surgery had none.14PubMed. Risk of hematoma complications after device implant in the clopidogrel era
Major bleeding complications requiring transfusion or surgery occurred in about 3.6% of patients on dual antiplatelet therapy in one registry.15PubMed Central. Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy These are almost never fatal, but the management of blood thinners around surgery is one of the more consequential decisions your cardiologist will make.
Anesthesia During Implantation
Pacemaker implantation is usually done with local anesthesia and mild sedation rather than general anesthesia, which eliminates some of the risk associated with major operations. Still, the patients receiving these devices often have fragile hearts. A retrospective study found that cardiopulmonary resuscitation was required during the procedure in a small number of patients, with acute heart failure being the strongest predictor of needing CPR and of 30-day death. Deeper sedation and general anesthesia were associated with higher odds of requiring resuscitation compared with lighter anesthetic approaches.16IJC Heart & Vasculature. Anesthetic practice during cardiac implantable electronic device implant procedures: A retrospective, single-center study Reassuringly, the same study found that the rate of CPR events decreased over time, suggesting improvements in monitoring and patient selection.
Lead Extraction Is Where Risk Climbs
If the discussion so far has focused on the initial implantation, it is because that procedure carries relatively low mortality. The risk picture changes when leads need to come out. Lead extraction is a separate operation performed because of infection, lead malfunction, or device recall, and it is considerably more dangerous than putting a pacemaker in.
The FDA received reports of 57 deaths and 48 serious injuries associated with device-assisted lead extraction between 1995 and 2008. Of those patients who underwent emergency surgical repair for heart perforations or vein lacerations during extraction, only about 56% survived.17EP Europace. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction A multicenter registry found a procedure-related death rate of 1.1% in patients undergoing lead-related revisions, which is several times higher than the mortality for a fresh implant.18EP Europace. The role of transvenous lead extraction in the management of redundant or malfunctioning pacemaker and defibrillator leads post ELECTRa
This is why cardiologists often leave old, non-functional leads in place rather than removing them. Extraction carries real danger, and abandoning a lead is usually safer unless infection forces the issue.19PubMed Central. Complications and lead extraction in cardiac pacing and defibrillation Patients facing a lead extraction should understand that it is a different procedure with different stakes than their original implantation.
Who Faces Higher Risk?
Individual risk varies enormously. A relatively healthy 65-year-old getting a pacemaker for a slow heart rate faces a very different risk profile than an 85-year-old with kidney failure, prior strokes, and advanced heart failure. Research has identified several factors that consistently predict worse outcomes.
A 10-year follow-up study found that patients with more coexisting medical conditions, advanced heart failure symptoms, and any post-procedural complications had significantly higher mortality after implantation.20PubMed Central. Predictors of complications and mortality among patients undergoing pacemaker implantation in resource-limited settings: a 10-year retrospective follow-up study In very elderly patients specifically, kidney failure, active cancer, connective tissue disorders, and cerebrovascular disease were each independently associated with worse survival after pacemaker implantation.21European Journal of Internal Medicine. Prognosis after pacemaker implantation in extreme elderly
Emergency implantation also carries more risk than a planned procedure. In the Australian study, emergency admissions had higher mortality across the board compared with elective ones. Emergency patients tended to be sicker and to have more cardiac conditions at baseline, which explains much of that gap.2PubMed. Using quality indicators to compare outcomes of permanent cardiac pacemaker implantation among publicly and privately funded patients
Does the Surgeon’s Experience Matter?
Yes, and more than the hospital’s reputation. A Dutch study found that the overall hospital volume did not independently affect complication rates, but the cumulative experience of the individual operator did.22PubMed Central. Quality of care: not hospital but operator volume of pacemaker implantations counts An older but frequently cited analysis found that physicians performing fewer than 12 implantations per year had a substantially higher complication rate, particularly for lead-related problems.23Journal of the American College of Cardiology. Pacemaker-implantation complication rates: An analysis of some contributing factors
A large German registry of over 75,000 implantations confirmed this pattern at the institutional level: the lowest-volume hospitals had the highest surgical complication rates, with the biggest jump in risk occurring between the two lowest-volume groups. Lead dislodgement rates also dropped steadily as hospital volume increased.24EP Europace. Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme If you have any choice in the matter, going to a center that does a high volume of implants and asking about your operator’s personal experience is one of the few things you can actively do to reduce your risk.
Leadless Pacemakers and Their Different Risk Profile
Leadless pacemakers, which are tiny capsule-shaped devices implanted directly inside the heart through a catheter in the leg, eliminate several of the traditional risks. There is no surgical pocket to get infected, no lead running through the veins that can fracture or dislodge in the conventional sense, and no subclavian puncture that can cause pneumothorax.
A retrospective comparison found that conventional pacemakers had dramatically higher rates of electrode dislodgement and pocket site infection compared with leadless devices.25PubMed Central. Complications of leadless vs conventional (lead) artificial pacemakers – a retrospective review No cases of leadless pacemaker infection have been reported in clinical trials enrolling more than 3,000 patients.10Heart Rhythm. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms
Leadless devices are not risk-free, though. A systematic review and meta-analysis found that the procedure-related death rate was about 0.3%, and pericardial tamponade occurred in roughly 1.4% of patients, which is a somewhat higher tamponade rate than seen with conventional implantation.26Indian Pacing and Electrophysiology Journal. Efficacy and safety of leadless pacemaker: A systematic review, pooled analysis and meta-analysis The trade-off is essentially less risk from infection and lead problems, but slightly more risk of heart perforation during the implant. For patients at high infection risk, like those on dialysis or those who have had prior device infections, the leadless option can be a meaningful safety improvement.
When the Device Itself Fails
It is worth knowing that risk does not end the day you leave the hospital. Pacemaker recalls, while uncommon, can involve life-threatening malfunctions. In December 2024, Boston Scientific recalled 203,000 pacemakers because of a software defect that could trigger a “safety mode,” causing the device to misinterpret skeletal muscle signals as heartbeats and stop pacing entirely. The FDA classified it as a Class I recall, meaning there was a reasonable probability of serious harm or death. A similar earlier recall of the same manufacturer’s devices was linked to three deaths.27PubMed Central. Complications Associated with Safety Mode Initiation in Recalled Boston Scientific Pacemakers These events are rare in the grand scheme of how many pacemakers are implanted each year, but they are a reminder that the device is a permanent implant requiring ongoing follow-up.
Long-Term Heart Damage From Pacing Itself
Even when the surgery and the device work perfectly, there is a recognized long-term risk from pacing itself. Pacing-induced cardiomyopathy occurs when the artificial electrical signal delivered by the pacemaker gradually weakens the heart’s pumping ability over time. This happens because pacing the right ventricle creates a slightly abnormal contraction pattern, and over months or years, that pattern can take a toll. Estimates suggest this affects roughly 10% to 20% of patients who receive frequent right ventricular pacing.28PubMed Central. Pacing-Induced Cardiomyopathy
A study of 823 patients with complete heart block and initially normal heart function found that about 12% developed this condition over an average of four years. Patients whose hearts were paced a higher percentage of the time were at greater risk, and the difference was striking: those paced 20% or more of the time had nearly seven times the risk of developing cardiomyopathy compared with those paced less often.29Heart Rhythm. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function This is not a surgical complication in the traditional sense, but it is a real health consequence of having a pacemaker that your doctor should monitor for and, in some cases, can address by upgrading to a device that paces the heart in a more synchronized way.
The Mental Health Side
Something that rarely comes up in discussions of pacemaker safety is the psychological impact. A large study of young people who received cardiac implanted devices found that both pacemaker and defibrillator recipients had a significantly higher risk of developing mental health disorders compared with matched individuals who did not receive a device. The elevated risk was highest in the first two years after implantation but persisted beyond that window as well.30PubMed Central. Mental Disorders After Cardiac Implantable Electronic Device Implantation in Young Individuals
Among pacemaker patients specifically, about 16% experienced some degree of anxiety and about 13% experienced depression in one cross-sectional study, both lower than rates seen in defibrillator patients but still clinically meaningful.31PubMed Central. Evaluatıon of Depressıon and Anxıety Status in Patıents After Cardıac Devıce Implantatıon Living with a device inside your chest, wondering whether it is working, and knowing your heart depends on a battery can produce real anxiety, particularly in younger patients who face decades of device management. While this is not a surgical mortality risk, it is a genuine health consequence that deserves acknowledgment and, when needed, treatment.
Sudden Death in Pacemaker Patients Over Time
An older but informative study tracked causes of death in pacemaker patients and found that the pattern depended heavily on why the pacemaker was implanted in the first place. Patients who had received their pacemaker for recurrent fainting spells (Adams-Stokes attacks) had a notably higher rate of sudden death, around 12% to 13%, and this risk was highest in the first year after implantation.32European Heart Journal. Survival rate and causes of death in patients with pacemakers: dependence on symptoms leading to pacemaker implantation Among patients paced for heart failure, more than half of those who died eventually succumbed to heart failure despite the pacemaker. The device corrects the rhythm problem, but it does not cure the underlying disease. Understanding this distinction helps frame what a pacemaker can and cannot do: it is a treatment for abnormal electrical signaling, not a fix for a structurally damaged or weakened heart.